Technical Analysis for XLRN - Acceleron Pharma Inc.

Grade Last Price % Change Price Change
grade B 43.9 -4.98% -2.30
XLRN closed down 4.98 percent on Friday, September 13, 2019, on 1.51 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical XLRN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
MACD Bullish Signal Line Cross Bullish -5.83%
Pocket Pivot Bullish Swing Setup -5.83%
NR7 Range Contraction -5.83%
Up 3 Days in a Row Strength -5.83%
Up 4 Days in a Row Strength -5.83%
Up 5 Days in a Row Strength -5.83%
20 DMA Support Bullish -4.17%
Golden Cross Bullish -4.17%

Older signals for XLRN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes (MDS), and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Biotechnology Cancer Life Sciences Rare Diseases Tumors Anemia Myelodysplastic Syndrome Celgene Therapeutics For Cancer Ace 536 Myelodysplastic Syndromes
Is XLRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 59.59
52 Week Low 37.01
Average Volume 255,552
200-Day Moving Average 43.3503
50-Day Moving Average 43.6522
20-Day Moving Average 45.099
10-Day Moving Average 44.917
Average True Range 1.5901
ADX 13.39
+DI 17.1662
-DI 19.8482
Chandelier Exit (Long, 3 ATRs ) 42.5997
Chandelier Exit (Short, 3 ATRs ) 47.1803
Upper Bollinger Band 47.4256
Lower Bollinger Band 42.7724
Percent B (%b) 0.24
BandWidth 10.317745
MACD Line 0.3962
MACD Signal Line 0.4468
MACD Histogram -0.0506
Fundamentals Value
Market Cap 1.69 Billion
Num Shares 38.6 Million
EPS -2.49
Price-to-Earnings (P/E) Ratio -17.63
Price-to-Sales 108.28
Price-to-Book 7.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.76
Resistance 3 (R3) 48.15 47.26 47.11
Resistance 2 (R2) 47.26 46.28 47.06 46.90
Resistance 1 (R1) 45.58 45.67 45.14 45.19 46.68
Pivot Point 44.69 44.69 44.47 44.49 44.69
Support 1 (S1) 43.01 43.71 42.57 42.62 41.12
Support 2 (S2) 42.12 43.10 41.92 40.90
Support 3 (S3) 40.44 42.12 40.69
Support 4 (S4) 40.05